AN IN-VITRO MODEL FOR ABNORMAL SKELETAL DEVELOPMENT IN THE LYSOSOMAL STORAGE DISEASES

被引:0
|
作者
AULTHOUSE, AL
ALROY, J
机构
[1] TUFTS UNIV,SCH MED & VET MED,DEPT PATHOL,BOSTON,MA 02111
[2] TUFTS UNIV NEW ENGLAND MED CTR,BOSTON,MA
来源
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY | 1995年 / 426卷 / 02期
关键词
G(M1)-GANGLIOSIDOSIS; CHONDROCYTES; TISSUE CULTURE; BONE RETARDATION;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Lysosomal storage diseases such as G(M1)-gangliosidosis are associated with skeletal abnormalities. Radiological and histological studies, both in human and corresponding animal models, indicate retarded bone formation. Since cartilage maturation leads to bone formation, we developed an in vitro system to study and compare the biological features of cartilage from dogs affected with G(M1)-gangliosidosis with age-matched controls. Costochondral chondrocytes were grown in monolayer and in agarose culture. Both affected and control cells dedifferentiated in monolayer; however, in agarose culture they re-expressed the chondrocytic phenotype. Cells from affected dogs were enlarged and contained numerous large vacuoles when compared with control cells. This morphology was similar to that seen in vivo. In addition, the affected cells appeared to have a reduction in mitosis and alcian blue staining proteoglycans. Cultures from affected animals contained fewer cells positive for alkaline phosphatase activity. Both affected and control cells expressed collagen types I and II and were positive for the lectin Ricinus communis agglutinin-I. However, the staining of the control culture for type II collagen was more prominent than in the affected cells. These findings suggest that culture of chondrocytes in agarose may be a useful method for studying the biology of cartilage which leads to skeletal abnormalities in lyse somal storage diseases.
引用
收藏
页码:135 / 140
页数:6
相关论文
共 50 条
  • [1] SKELETAL LESIONS IN LYSOSOMAL STORAGE DISEASES
    ORGAD, U
    SCHELLING, S
    ALROY, J
    ROSENBERG, A
    SCHILLER, A
    LABORATORY INVESTIGATION, 1989, 60 (01) : A68 - A68
  • [2] Skeletal Abnormalities in Lysosomal Storage Diseases
    Stevenson, David A.
    Steiner, Robert D.
    PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2013, 10 : 406 - 416
  • [3] LYSOSOMAL STORAGE DISEASES
    GIESELMANN, V
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1995, 1270 (2-3): : 103 - 136
  • [4] Disease models for the development of therapies for lysosomal storage diseases
    Xu, Miao
    Motabar, Omid
    Ferrer, Marc
    Marugan, Juan J.
    Zheng, Wei
    Ottinger, Elizabeth A.
    TARGETING THE LYSOSOME, 2016, 1371 : 15 - 29
  • [5] THE LYSOSOMAL STORAGE DISEASES
    OBRIEN, JF
    MAYO CLINIC PROCEEDINGS, 1982, 57 (03) : 192 - 197
  • [6] Lysosomal storage diseases
    Platt, Frances M.
    d'Azzo, Alessandra
    Davidson, Beverly L.
    Neufeld, Elizabeth F.
    Tifft, Cynthia J.
    NATURE REVIEWS DISEASE PRIMERS, 2018, 4
  • [7] LYSOSOMAL STORAGE DISEASES
    不详
    LANCET, 1986, 2 (8512): : 898 - 899
  • [8] Lysosomal storage diseases
    Frances M. Platt
    Alessandra d’Azzo
    Beverly L. Davidson
    Elizabeth F. Neufeld
    Cynthia J. Tifft
    Nature Reviews Disease Primers, 4
  • [9] LYSOSOMAL STORAGE DISEASES
    BRADY, RO
    PHARMACOLOGY & THERAPEUTICS, 1982, 19 (03) : 327 - 336
  • [10] Lysosomal storage diseases
    Edward M. Kaye
    Current Treatment Options in Neurology, 2001, 3 (3) : 249 - 256